New details about the first human study of Moderna’s experimental coronavirus vaccine emerged, which researchers said reinforced their decision to take the shot into a large, decisive clinical trial
New details about the first human study of Moderna Inc.’s experimental coronavirus vaccine emerged Tuesday, which researchers said reinforced their decision to take the shot into a large, decisive clinical trial scheduled to start in late July.
The new results, published online by the New England Journal of Medicine, showed that the vaccine induced the desired immune response for all 45 people evaluated—a larger group than in the preliminary data Moderna released in May—and was generally safe and well-tolerated.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Moderna expects to start late-stage COVID-19 vaccine trial on July 27Moderna Inc said on Tuesday it plans to start a late stage clinical trial for its COVID-19 vaccine candidate on or around July 27, according to its listing for the phase 3 study at clinicaltrials.gov.
Read more »
Development of full Covid-19 vaccine to take 'several years'Although there is an unprecedented effort to develop a coronavirus vaccine, the complete success will take years, says a French epidemiologist who is part of a team of scientists that advises the government on the crisis.
Read more »
Russia Completes Human Trials Of Covid-19 VaccineRussia said their version of a coronavirus vaccine shows promise, with many people showing signs of immunity.
Read more »
Moderna stock price could surge another 45% on COVID-19 vaccine - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Read more »
U.S. COVID-19 vaccine program to start manufacturing by late summer, says U.S. officialDrugmakers partnered with the U.S. government are on track to begin actively manufacturing a vaccine for COVID-19 by the end of the summer, a senior administration official said on Monday.
Read more »
'They needed people': Brazil volunteers step up to test COVID-19 vaccineLuiz Augusto Rizzo, 29, is no specialist in infectious diseases, but he is part of perhaps the most important scientific endeavor in the world today: the hunt for a vaccine against the novel coronavirus.
Read more »